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Abstract 
The current study examined a large cohort of untreated Chronic Fatigue Syndrome patients at initial assessment 
and at specific time points over a three-year period.  Methods used in previous studies to assess patient health, 
were validated and used to assess recovery and improvement.  Possible predictors of outcome would then be 
identified by assessing improvements in health status at specific follow-up points. The illness was also assessed 
in terms of recovery and improvement by using health related and psychosocial measures together with the 
aetiology of the illness.  These were further used to investigate possible mechanisms influencing or predicting 
recovery or improvement. Two-hundred and twenty-six patients completed wide ranging questionnaires at initial 
assessment and again six and eighteen months and three years later.  A current state of health score was used to 
measure recovery over time and analyses conducted to investigate the relationship between this and other health 
related measures.  Regression analyses were conducted to assess predictors of improvement and recovery. 
Spontaneous recovery rates in the untreated patient at three-year follow-up were low (6%).  The data suggested, 
however, that illness length, symptom severity and health status have an important role in recovery.  Although 
there was no evidence to suggest an association between illness onset type and subsequent recovery or 
psychopathology scores at initial assessment and recovery, regression analyses did indicate that levels of 
anxiety, cognitive difficulties and social support at initial assessment predict a positive outcome. The state of 
health measure was validated as a method of accurately assessed the health status of patients and was used as an 
indicator of improvement and recovery within this group.  Spontaneous recovery in the patient group was 
associated with several factors measured at initial assessment. However, further studies are necessary to more 
fully identify the factors which affect recovery or improvement and to investigate the exact nature of the 
mechanisms involved. The present study shows that spontaneous recovery of CFS patients is rare. Treatment or 
management is essential, and the efficacy of different approaches must be assessed. 
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1. Introduction 
 
The fatigue experienced in Chronic Fatigue Syndrome (CFS) is not only of sufficient severity to cause 
substantial functional impairment but is accompanied by four or more co-existing symptoms including those of a 
cognitive or neuropsychiatric nature (Centre for Disease Control (CDC) criteria; Fukuda et al., 1994).  The 
illness (by definition) must be of at least six months duration and can become very debilitating and persistent 
(Andersen, Permin & Albrecht, 2004). 
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In order to provide insight into the prevalence of CFS, Afari and Buchwald conducted an in-depth appraisal of 
the literature (Afari & Buchwald, 2003).  Evidence from epidemiological studies suggested that, in large scale 
surveys, up to half the general population would report suffering fatigue-like symptoms (Chen, 1986; 
Pawlikowska et al., 1994) and 20% of this group would subsequently seek medical care (Bates et al., 1993; 
Cathebras, Robbins, Kirmayer & Hayton, 1992; David et al., 1990; Kroenke et al., 1988; McDonald, David, 
Pelosi & Mann, 1993).  However, in the majority of these cases, the fatigue experienced could be explained by 
other mitigating circumstances.  Therefore, the incidence of CFS in the general population, the review 
concluded, is relatively low.  Similarly, Price et al. (1992) reported findings from a community-based survey 
suggesting that 7.4 per 100,000 of the population (0.0074%) fulfilled the CDC criteria for CFS.  More recently, 
Ranjith’s review of the literature also agreed that, although the symptom of fatigue is common, cases of 
medically unexplained fatigue that fulfil the CDC criteria are somewhat rare (Ranjith, 2005).  The relatively low 
incidence of CFS should not, however, detract from the severe effect the illness has on the individual sufferer’s 
quality of life.  Decreased personal, occupational and social activities combine to instil a sense of frustration and 
hopelessness within the patient.  In addition, financial concerns have been raised regarding the increased uptake 
of unemployment benefits and the drain on healthcare resources caused by the illness.  Data collected as part of 
the CDC’s surveillance study (Reyes et al., 1999) estimated that the cost in terms of lost productivity, per 
annum, for each CFS patient in the United States was $20,000.  In the light of this, continued research into the 
causes of and potential therapies for CFS are vital to alleviate this financial burden (Reynolds, Vernon, 
Bouchery & Reeves, 2004). 
 
Before coherent treatment protocols were in place, research mainly concentrated on investigations into the long-
term prognosis of CFS.  These longitudinal studies also attempted to calculate recovery rates and identify 
possible predictors of positive outcome.  However, when reviewing the literature, it became apparent that several 
different criteria had been used to define recovery in the patient group.  For example, a patient in recovery (or 
remission) was described in one study as; (a) no longer suffering from fatigue, (b) experiencing less than four 
CFS related symptoms and, (c) a person whose health no longer interfered with normal activities (Reyes et al., 
1999).  When these criteria were applied, spontaneous recovery was calculated at 31.4% during the first five 
years of the illness (Reyes et al., 1999).  Similarly, an assessment of 98 consecutive referrals to a specialised 
CFS clinic produced data suggesting that 41% of the sample were moderately to completely recovered two to 
three years post-baseline.  Furthermore, 2.6% of these patients rated themselves as ‘fully recovered’ and 29.5% 
had returned to work (Russo et al., 1998).  The issue of CFS and recovery was raised in a discussion by Cairns 
and Hotopf (2005) which highlighted inconsistencies in the literature.  The review concluded that although 
improvement in patients at follow-up ranged from 8 to 63%, full recovery from the illness was actually quite 
rare.  
 
CFS patients themselves are well aware that short periods of remission are common and can occur at any time 
during the illness.  However, several studies have indicated that bouts of recovery are more likely in patients 
with short illness duration (Reyes et al., 1999; Nisenbaum, Jones, Jones & Reeves, 2000).  Furthermore, there is 
evidence to suggest that several other factors may also influence recovery, including younger age (at onset), 
fewer physical symptoms, higher mental and general health scores and low levels of emotional distress at 
baseline (Russo et al., 1998).  In addition, low levels of fatigue (at baseline), a sense of control over the 
symptoms associated with the illness and, the attribution of non-physical cause have also been linked with more 
favourable outcomes (Cairns & Hotopf, 2005). 
 
Overall, when reviewing previous studies assessing recovery within this patient group it appeared that there were 
several crucial points that needed to be addressed.  Firstly, the method used to define recovery should be as clear 
cut as possible.  Each patient’s perception of recovery will differ, that is, one patient’s idea of recovery may not 
correspond to that of another.  It might be more appropriate in illnesses such as CFS, therefore, to measure 
improvements within an individual sufferer’s health rather than using a ‘one size fits all’ approach.  This, in turn, 
would affect the choice of parameter(s) used to measure it.  In the particular case of CFS these problems are 
further confounded by reports from sufferers of periods of remission throughout the illness.  Ideally, therefore, 
several independent measures should be used to assess the validity of the recovery measure.  In addition, the 
evaluation process must be capable of differentiating between true recovery and bouts of remission.  The final 
point to consider is intervention.  Longitudinal studies are, by definition, conducted over several years.  
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Although the studies reviewed were not part of any specific treatment protocols, it can not be assumed that the 
patients questioned did not attend some form of therapy during the intervening time period.  Therefore, these 
data might not represent the true nature of the illness and this may be being reflected in high recovery rates. 
 
Previous research had already highlighted several aspects of the disorder, such as psychopathology, ratings of 
well-being, psychosocial and demographic factors, which may affect outcome (Smith, Behan, Bell, Millar & 
Bakheit, 1993).  CFS patients had been studied using a wide range of questionnaires and these data had indicated 
that there were possible confounding variables that affect the severity of CFS including psychosocial factors, 
support mechanisms, health measures and psychopathology (Smith, Pollock, Thomas, Llewelyn & Borysiewicz, 
1996; Smith, Borysiewicz, Pollock, Thomas & Llewelyn, 1999).  The severity of the illness was assessed by 
means of physical symptoms (Cohen & Hoberman, 1983; Smith et al., 1996), fatigue related symptoms (Ray, 
Weir, Stewart, Millar & Hyde, 1993), cognitive failures (Broadbent, Cooper, Fitzgerald & Parkes, 1982) and a 5-
item health status measure (Smith et al., 1996).  Psychosocial aspects of the disorder such as stress (Cohen, 
Kamarack & Mermelstein, 1983), social support (Henderson, Bryne & Duncan-Jones, 1981), self-esteem 
(Fleming & Watts, 1980) and the impact of inter-current life events (Cohen & Hoberman, 1983) were also 
assessed using several measuring instruments.  Furthermore, measures of psychopathology (Beck, Ward, 
Mendelson, Mock & Erbough, 1961; Radloff, 1997; Spielberger, Gorsuch & Lushene, 1971), health related 
behaviours and illness history (Smith et al., 1996) were included in the study in an attempt to provide a more 
comprehensive picture of this complicated and debilitating illness.   
 
With these measuring instruments in place, the aim of the current study was, in the first instance, to describe the 
characteristics of a large cohort of CFS sufferers at initial assessment and validate a measure for accurately 
measuring the health status of the individual patient.  When validated, this measure was used to define and 
assess recovery and investigate possible predictors of outcome by comparing the health and psychosocial 
measures (at initial assessment) of patients who recovered over a three-year period to those who did not recover.  
These data also allowed us to monitor the natural progression of the untreated illness over time. 
 
2. Method 
 
2.1 Design 
The study was longitudinal in nature, with assessments occurring at initial assessment (baseline), six and 
eighteen months and three years later. 
 
2.2 Participants 
Ethical approval for the study was granted by the relevant local Health Authority.  Potential volunteers were 
informed that the research was being conducted as part of a long-term project investigating CFS and, that they 
would be asked to complete similar test batteries over a period of time as part of a research panel.  Participation 
in the study was voluntary and all participants gave written, informed consent.  Patient data were coded to ensure 
anonymity. 
 
The research panel comprised consecutive GP referrals over a 7 year period to a specialised CFS outpatient 
clinic meeting the CDC criteria for Chronic Fatigue Syndrome.  Patient volunteers were assessed at initial clinic 
visit (baseline), at six and eighteen months and again three years later.  As there was no formal treatment 
available to these patients at that time, the data represents the untreated illness.  However, a small number of 
participants were taking antidepressant therapy at baseline.  Data from these patients were not included in the 
final analyses. 
 
2.3 Materials and Method 
The CFS volunteers completed wide ranging questionnaires developed to measure global ratings of well-being, 
sleep and psychopathology and established indicators of quality of life (Smith et al., 1996; Smith et al., 1999).  
Demographic data relating to the sample were collected, along with an illness history questionnaire and a 28-
item symptom check-list.  The resulting data were then used to examine associations between these measures 
and recovery or improvement. 
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2.3.1 Measurement of Recovery 
Health status and severity were measured by a ‘current state of health measure’ (Smith et al., 1996).  This 5-item 
scale categorised the patient’s health as follows: (1) worse than at any stage of the illness; (2) bad; (3) bad with 
some recovery; (4) recovering with occasional relapses and (5) almost completely recovered.  In order to test the 
validity of this measure to accurately describe health status at any given time, patients were categorised into two 
groups at baseline: those who were in poor health (scoring ‘worse than any stage’, ‘bad’ and ‘bad with some 
recovery’) and those who thought they were recovering (scoring ‘recovering with occasional relapse’ and 
‘almost completely recovered’).  These baseline data were then compared to measures known to be associated 
with the illness, including: (a) positive and negative mood (Zevon & Tellegen, 1982); (b) depression (Beck et al., 
1961; Radloff, 1997); (c) anxiety (Spielberger et al., 1971); (d) fatigue related symptoms (Ray et al., 1993); (e) 
physical symptoms (Cohen & Hoberman, 1983; Smith et al., 1996); (f) cognitive failures (Broadbent et al., 
1982) and, (g) stress (Cohen et al., 1983).   
 
Once validated, if measurable recovery was indicated at follow-up, we would then be able to identify factors at 
baseline that appear to be linked with recovery and, therefore, predict recovery later on.  Improvement was also 
measured with the 5-item current state of health score by examining differences between the follow-up and 
baseline scores. 
 
Recovery and improvement were then used as outcome measures.  By comparing these data to other health 
related outcomes known to be associated with exacerbating and prolonging the illness we investigated possible 
predictors of outcome. 
 
2.4 Procedures 
The various measuring instruments were administered in the form of two questionnaire booklets.  The first 
booklet concentrated on measures of a general nature, such as demographic and illness history data (Smith et al., 
1996), cognitive failures, perceived stress and social support which could be completed by the patients at home 
in their own time.  The second booklet required responses to subjective measures such as, anxiety, depression 
and fatigue related symptoms, which referred to the previous week. 
 
Patients also responded verbally to a range of questions relating to illness beliefs, including type of onset (acute 
or gradual) and events which were thought to have preceded the illness.  These data were recorded by research 
registrars at initial clinic visit. 
 
2.5 Data Analysis 
Continuous data were run through analysis of variance and categoric data from the study were run through Chi-
Squared cross-tabulation analyses to describe the nature of the sample at initial assessment (baseline).  Two-way 
contingency table analyses (Chi-Square) were carried out to investigate the relationship between: (a) the current 
state of health variable and other health measures and (b) the current state of health variable and psychosocial 
factors.  Recovery and improvement were used as grouping variables in independent sample t-test analyses.  
Logistic regression analyses were conducted to assess predictors of improvement and/or recovery using the 
health and psychosocial measures.  A further model was created which complied with findings discussed by 
Cairns and Hotopf (2005).  That is to say, age, illness length, illness onset type, physical cause, total symptoms, 
fatigue, health status and emotional distress have all been previously indicated as predictors of outcome. 
 
3. Results 
 
In all, 307 CFS patients were recruited to the research panel.  Patients taking antidepressant medication at 
baseline and for those whom antidepressant medication status was unknown (n=81) were excluded from the final 
analyses.  130 patients completed the baseline, six and eighteen months and three years later.   
 
3.1 Patient Sample and Illness Characteristics 
Table 1 describes the basic demographic data for the 226 patients at baseline which follows the profile one 
would expect in CFS.  The majority of the patients fell into the ‘bad with some recovery’ category of the current 
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state of health variable (43%) and the mean total symptom score (calculated from the 28-item check list) was 
15.84 (s.e.m=0.36).  The mean illness length was approximately 5 years.  
 
Table 1: Baseline Demographic and Illness History data for the original cohort of CFS patients and the final 
cohort who completed the study. 
 
Baseline Measures Original Cohort 
(n=226) 
Final Cohort 
(n=130) 
Gender: 
 
Male 
Female 
31% 
69% 
34% 
66% 
Mean Age: 41.7 (0.80) 45.05 (1.15) 
Marital Status: 
 
Single 
Married 
Divorced/ Separated 
Widowed 
21% 
65% 
10% 
3% 
10% 
75% 
9% 
5% 
Educational  
Status: 
 
No Formal Schooling 
Primary Education only 
Secondary Education 
O Levels 
A Levels 
At least 1yr at University  
BSc or BA 
MSc or MA 
PhD, MD, etc 
0 
0 
29% 
33% 
9% 
7% 
16% 
2% 
3% 
0 
0 
30% 
31% 
9% 
8% 
17% 
2% 
2% 
Illness Duration (months): 62.13 (3.84) 65.49 (5.83) 
Current State of 
Health: 
 
Worse than at any stage 
Bad 
Bad with some recovery 
Recovering with relapses 
Almost completely recovered 
8% 
20% 
43% 
38% 
0.9% 
6% 
15% 
43% 
36% 
0 
Total Symptom Score (maximum = 28): 15.84 (0.36) 16.32 (0.59) 
 
In addition, the majority of patients (68%) had their condition diagnosed by their GP and 34% of the sample was 
in employment at the time of initial assessment.  49% were unemployed and 16% were on sick leave.  These 
groups represented 76% of the total sample (the rest of the sample being either retired or home-makers).  Of the 
patients who were working, 21% believed that their job security was threatened by the illness.  Respondents who 
reported trying alternative therapies to alleviate their symptoms spent on average £235 doing so.  Less than half 
of these patients believed that they had received value for money by taking the alternative therapy route.   
 
3.2 Health Measures 
Re-examining the sample in terms of type of illness onset (that is, acute or gradual onset) provided no significant 
differences with regard the demographic nature, illness history or total symptom scores of the sample. 
 
The majority of patients (84%) believed that a specific event had proceeded, and therefore, may be attributed to 
their illness.  The majority of these (42%) suggested that influenza was the causal agent.  We found no evidence 
to suggest that there might be a link between type of onset (acute or gradual) and the patient’s belief that a virus 
had caused the illness.  Table 2 goes on to describe the 28-item symptom check-list for the group at baseline in 
detail. 
 
Table 2: The Symptom Checklist Scores for the patient group at baseline.  Scores are ranked most to least 
prevalent. 
 
Symptom % Symptom % 
Lack of concentration 
Muscle pain 
(back, arms or legs) 
Excessive fatigue 
Physical weakness 
91 
89 
 
87 
81 
Sensitivity to light 
Sore throat 
Wind 
Insomnia 
Nausea 
53 
52 
49 
47 
46 
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Legs feeling heavy 
Fever 
Loss of memory 
Headache 
Aching joints 
Sensitivity to noise 
Bloated stomach 
Sweating 
Sore eyes 
80 
77 
76 
70 
69 
59 
55 
54 
53 
Shivering 
Glands swollen 
Racing heart 
Chest pain 
Indigestion 
Panic attacks 
Depression 
Allergies 
Earache 
45 
45 
44 
44 
41 
40 
37 
35 
33 
 
These data indicate that muscle pain, lack of concentration and excessive fatigue were the highest rated 
symptoms in the patient group. 
 
3.3 Comparability of the Follow-up Sample 
Chi-squared cross-tabulation and analysis of variance were used to compare the baseline demographic and 
illness history data from members of the original CFS cohort assessed at baseline (n=226) to those completing 
all follow-up sessions (n=130).  Table 1 indicates that the original cohort assessed at baseline have comparable 
data at baseline, in terms of gender, age, marital and educational status to those completing all assessment 
session.  In addition, there were no significant differences between the two samples in respect to length of 
illness, health status and total symptom scores at initial assessment (baseline). 
 
3.4 Validation of the Health Status Measure 
The following table presents data in relation to the patient’s current state of health at baseline.  Patients in the 
‘recovering’ group had fewer symptoms at baseline than those in the ‘not recovering’ group.  Table 3 indicates 
further associations between the current state of health measure and physical and mental health variables. 
 
Table 3: The relationship between Current State of Health at baseline and Health Outcomes. ‘Recovering with 
occasional relapses’ and ‘Almost completely recovered’ represent the ‘Recovering’ group, the remaining values 
represent the ‘not recovering’ group.  Values are the group means with s.e.m in parenthesis. 
 
 Baseline Current State of Health 
 Not Recovering Recovering P value 
Baseline Measures:    
Positive Mood 
Negative Mood 
25.02 (0.74) 
24.66 (0.92) 
29.44 (1.19) 
20.28 (1.21) 
0.002 
0.009 
CES_depression 42.21 (0.82) 37.78 (1.25) 0.004 
State Anxiety 41.20 (0.83) 37.25 (1.14) 0.009 
PFRS 
 
Emotional Distress 
Fatigue 
Cognitive Difficulties 
Somatic Symptoms 
49.04 (1.73) 
67.22 (1.05) 
49.33 (1.21) 
57.56 (1.56) 
42.36 (2.50) 
53.95 (2.07) 
41.47 (1.95) 
44.97 (2.17) 
0.036 
0.000 
0.001 
0.000 
BDI 16.20 (0.66) 12.28 (0.82) 0.001 
Cohen-Hoberman Inventory of Physical 
Symptoms 
27.02 (0.60) 20.36 (0.92) 0.000 
Six Month Follow-up Measures:    
PFRS 
 
Fatigue 
Somatic Symptoms 
62.42 (1.59) 
55.39 (2.17) 
54.39 (2.55) 
45.82 (2.60) 
0.007 
0.011 
Inventory of Physical Symptoms 25.18 (0.82) 20.21 (1.23) 0.001 
Three Year Follow-up Measures:    
PFRS Fatigue 61.43 (2.02) 52.54 (2.92) 0.012 
Inventory of Physical Symptoms 23.92 (1.13) 20.02 (1.34) 0.031 
 
The data here provides clear-cut differences between the ‘recovering’ and ‘not recovering’ groups in terms of 
both emotional and health related scores at baseline.  As these health-related measures are often associated with 
the severity of the illness (Russo et al., 1998; Smith et al., 1993) the ‘current state of health’ variable also 
appears to accurately assess the true severity of the illness for each patient. 
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3.5 Health Measures and Recovery 
The topic of recovery over time was examined using the current state of health variable.  People responding 
‘almost completely recovered’ to this scale represented recovery.  The results suggest that very few patients will 
completely recover over time without treatment.  Levels of spontaneous recovery were only 2% at 6 months and 
rose to 6% at 18 months and 3 years.   
 
As the number of patients who completely recover over time was low, recovery was redefined as patients who 
were ‘recovering with occasional relapses’ and those who had ‘almost completely recovered’. 
When considering illness onset type, there was no evidence to suggest that an association existed with recovery 
either in terms of state of health measures or total symptom scores.  Similarly, there was no indication from the 
data that an association between the belief that physical or non-physical event caused the illness and recovery 
exists.  When considering illness length at baseline, there were no significant differences associated with current 
state of health (recovering/not recovering) or total symptom scores except with respect to recovery at three year 
follow-up.  To investigate this further, illness length was further split into quartiles and cross-tabulated with the 
recovering/not recovering variable.  Although there was no association between illness length and recovery at 
baseline, 6 and 18 months, there was an association between the lowest quartile history length group and the 
likelihood of recovery at three-year follow-up (df=3, p<0.032). 
 
3.6 Employment Status and Recovery 
Table 4 describes the employment status of the patient sample at baseline.  When comparing the three 
employment status groups there was an association between recovery and employment status at baseline, 
eighteen month and three-year follow-up.  Patients in the employed group were significantly more likely to 
recover over time than those that were unemployed or on sick leave at baseline.  
 
Table 4: The relationship between employment status at baseline and recovery at baseline, 18-months and 3 year 
follow-up.  ‘Recovering with occasional relapses’ and ‘Almost completely recovered’ represent the ‘Recovering’ 
group, the remaining values represent the ‘not recovering’ group. 
 
 EMPLOYMENT STATUS AT BASELINE  
 Employed 
 
Unemployed 
 
On sick leave P value 
Baseline:     
Not Recovering 
Recovering 
31 
52 
43 
43 
17 
14 
n/s 
Six Month Follow-up:     
Not Recovering 
Recovering 
27 
56 
35 
47 
17 
18 
n/s 
Eighteen Month Follow-up:     
Not Recovering 
Recovering 
19 
60 
54 
36 
21 
10 
0.000 
Three Year Follow-up:     
Not Recovering 
Recovering 
20 
67 
46 
40 
13 
14 
0.035 
 
3.7 Symptoms and Recovery 
The association between recovery at initial assessment (baseline) and two other health related measures namely, 
total symptom and fatigue scores were then examined at baseline, six month, eighteen month and three year 
follow-up.  Patients in the ‘recovering’ group at baseline reported significantly lower total symptom scores at 
baseline (recovering=13.71 (sem=0.69), not recovering=16.71 (sem=0.41), p<0.000), 6 months 
(recovering=12.89 (sem=0.93), not recovering=15.82 (sem=0.56), p<0.006) and 18 months (recovering=12.72 
(sem=0.86), not recovering=15.54 (sem=0.54), p<0.006).  
 
Fatigue in this cohort of patients was assessed using the Profile of Fatigue Related Syndromes questionnaire 
(PFRS).  When splitting these scores into quartile ranges, there was an association between fatigue levels at 
baseline and rates of recovery.  Patients who recorded low levels of fatigue at baseline were significantly more 
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likely to be in the ‘recovering’ group than those with high fatigue scores.  This association occurred at baseline 
(recovering=55%, p<0.000), 6 months (recovering=67%, p<0.000), 18 months (recovering=56%, p<0.001). 
 
3.8 Psychopathology and Recovery 
In terms of psychopathology, there was an association between low depression scores at baseline (BDI) and 
recovery at baseline (recovering=67.2%; not recovering=47.5%, df=1, p<0.006).  This trend was repeated at six-
month follow-up (recovering=70.7%; not recovering=44.6%, df=1, p<0.001).  This suggests that patients with 
lower depression scores at baseline were more likely to be in the recovering group.  The trend, however, did not 
continue at the three-year follow-up point.  There was no association between anxiety scores at baseline and 
subsequent recovery. 
 
3.9 Psychosocial Measures and Recovery 
The psychosocial measures administered in the current study included those assessing illness coping strategies, 
levels of perceived stress and daily hassles and levels of social support.  Previous studies had already highlighted 
the differences between the psychosocial data from the CFS population when compared to a group of healthy 
controls [Thomas & Smith, submitted].   
There were, however, no associations between baseline psychosocial measures and recovery at baseline, six 
months, eighteen months and three-year follow-up.   
 
3.10 Health Measures and Improvement 
Improvement was again calculated using the current state of health score.  Patient responses at baseline were 
subtracted from subsequent follow-up measures to calculate whether their health status was ‘improving’ or ‘not 
improving’ at that time point.  It is clear that when measuring recovery in terms of improvement, the percentages 
become much greater.  Improvement is rated at 25% at 6 month follow-up rising to 29% at 18 months and 3 
years. 
 
This measure was then run through a similar analysis process to the ‘recovering’/ ‘not recovering’ variables.  
However, these data did not show the clear-cut differences between observed when using the recovery variable. 
 
3.11 Psychosocial Measures and Improvement 
There no associations between improvement and these baseline scores.  One exception being positive life events 
at baseline: patients in the highest quartile of positive life events were significantly less likely to be in the 
improved group at 3 year follow-up (improved=9%; not improved=29%, df=2, p<0.029).  This implies that 
patients with the higher positive life events at baseline are least likely to improve three years later.  As we can 
offer no explanation as to why this should be the case, it is considered that this finding represents chance effect. 
 
3.12 Illness Characteristics and Health Measures as Predictors of Outcome 
Logistic regression analyses were used to examine the relationship between baseline questionnaire data and 
improvement at three-year follow-up.  Improvement was chosen as the dependant variable due to the low 
numbers of patients in the study who could be classified as recovered at the follow-up point (that is, only 6% of 
the sample).  Two models were created, the baseline predictor variables being; (a) the aetiology of the illness 
(illness onset type, length of illness, viral cause and health status at onset) and, (b) health measures (fatigue, 
emotional distress, somatic symptoms, cognitive difficulties, cognitive failures, total symptoms, physical 
symptoms, anxiety and depression).  There was no evidence to suggest that any of the health measures recorded 
at initial assessment were predictors of outcome.  However, in terms of the aetiology of CFS, the current state of 
health measure was indicated as a predictor of outcome.  Patients who reported better health status at initial 
assessment were significantly more likely to show improvement at the three-year follow-up point (OR=4.924, 
df=1, CI=1.453 – 16.688).  91 cases were used in the analysis and 70% of the sample was correctly classified by 
the prediction variables. Illness onset type, illness length and viral cause were not indicted as predictors of 
outcome. 
 
3.13 Psychosocial Measures as Predictors of Outcome 
There was no indication that any of the psychosocial factors measures at baseline could be described as 
predictors of improvement at three-year follow-up. 
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3.14 Further Regression Analyses 
Further logistical regression analyses were conducted to test whether certain factors discussed in the literature 
namely, age, illness length, illness onset type, viral cause, total symptom scores, fatigue scores, emotional 
distress scores and health status scores are predictors of outcome in CFS.  Again, only the current state of health 
of the patient at initial assessment (baseline) was indicated as a predictor of outcome at three-year follow-up 
(OR=9.618, df=1, CI=2.094 – 44.175).  89 cases were used in the analysis 75% of the sample were correctly 
classified by the prediction variables. 
 
4. Discussion 
 
The aims of the current study included the description of the demographic and illness characteristics of a large 
group of Chronic Fatigue Syndrome (CFS) patients at initial assessment, the validation of a measure (developed 
in previous studies) which could accurately evaluate health status and, therefore, recovery in the condition, and 
to identify factors which influence and predict positive outcome. 
 
The patients recruited onto the volunteer panel were consecutive GP referrals to a dedicated research clinic and 
were categorised by the Centre for Disease Control case definition for CFS (Fukuda et al., 1994).  The 
demographic data of the sample follows a similar profile to patients described by others Fukuda et al., 1997) and, 
therefore, the group comprises predominantly married females in their forties.  There has, in the past, been some 
debate as to whether an association between social classification and increased cases of Chronic Fatigue 
Syndrome exists (Fukuda et al., 1997; Dowsett, Ramsay, McCartney & Bell, 1990; Hinds & McClusky, 1993; 
Ho-Yen & McNamara, 1991).  Data from the current research indicates that the majority of the sufferers 
recruited to the study were grouped in the professional or semi-professional social categories confirming that 
patients with this illness are more likely to be members of a specific social grouping. 
 
The persistent and debilitating nature of the illness, demonstrated by a mean history length of five years and the 
number of symptoms present (16 of a possible 28), is apparent.  For example, in the case of total symptoms, one 
would expect scores of 3 from a group of healthy controls (Thomas & Smith, 2009).  The findings reported in 
the current study, therefore, indicate the wide range of symptoms associated with this illness.  Furthermore, 
symptoms such as lack of concentration, muscle pain, excessive fatigue, physical weakness and legs feeling 
heavy were reported in over 80% of the cases.  The length and severity of the illness is also reflected in the high 
numbers of patients who were either unemployed or on sick leave at initial assessment (baseline).   
 
The health status of the patient group was assessed by the 5-item current state of health variable (Smith et al., 
1996).  Applying this measure at initial assessment (baseline) revealed data indicating that the health status for 
the cohort was poor; the majority of the group (41%) rating their health as ‘bad with some recovery’.  Further 
analyses also suggests that the health status variable correlates negatively with other measures such as total 
symptoms scores, that is, lower scores on the current state of health measure are accompanied by increased total 
symptom scores. 
 
Considering that the patients described in the current study represented different stages of the illness in terms of 
severity and illness length, one might presuppose a link between the current state of health variable and the 
length of illness measure.  That is to say, either patients with longer illness length could be categorised as having 
greater illness severity or conversely, after a certain length of time, the patient begins to recover.  This, however, 
does not appear to be the case.  Cross-tabulation analyses reveals data indicating that illness length (represented 
by quartile ranges) is equally spread over the 5-items of the health status measure.   
 
The current state of health measure was also used to assess recovery.  Spontaneous recovery rates for the group 
are low at only 2% at six-month follow-up.  Furthermore, these rates did not improve a great deal eighteen 
months or three years later (6%).  The recovery rates reported here are much lower than those seen in previous 
studies (Reyes et al., 1999) but are in-keeping with results from a recent review by Cairns & Hotopf (2005) and 
a patient survey conducted by Thomas & Smith (2005), which indicate that the occurrence of spontaneous 
recovery from CFS is, in fact, relatively rare.  When changes (or improvement) in health status rather than 
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recovery were measured, 25% of the sample reported an improvement at six months follow-up.  These levels of 
improvement rose to 29% at eighteen months and remained constant at three years.  As both recovery and 
improvement are calculated from the same 5-item scale, the problems one might encounter when interpreting 
subjective data are highlighted.  Data from the improving/ not improving grouping did not provide the 
associations between state of health and improvement in other health-related measures that one sees in the 
recovery/ not recovering grouping.  However, these data do indicate that both recovery and improvement peak at 
the 18 month follow-up point in the untreated patient.   
 
Data linking state of health at baseline (recovering or not recovering) with other health-related measures at 
baseline, such as fatigue and depression, suggests that this measure can be used to accurately assess an 
individual patients’ health at any given point.  In addition, these data also demonstrate that illness status at 
baseline affects outcome i.e. better health status at baseline is associated with positive outcome at follow-up.   
 
There is also evidence to suggest that total symptom scores and shorter illness lengths, again at baseline, are 
associated with more favourable outcomes.  Overall, these data re-enforce the well held belief that diagnosing 
CFS effectively and setting coping and/or management strategies in place swiftly are vital to prevent the 
entrenchment of negative illness perceptions in patients and help facilitate positive outcome. 
 
There is no suggestion from these data that physical cause attribution is associated with outcome.  Similarly, 
there is no evidence to suggest that type of illness onset (acute or gradual) affects prognosis (although the type 
and frequency of symptoms reported by patients with acute or gradual illness onset do differ).  Furthermore, 
there is no evidence from these data to suggest that co-morbid anxiety or depression at baseline is associated 
with recovery in the longer term.  Physical cause, illness onset type and co-existing psychopathology have all 
been cited as possible factors affecting recovery in this patient group (Cairns & Hotopf, 2005; Russo et al., 
1998).  The data from the current study indicates that these associations may not exist.   
 
Of interest, however, is evidence linking employment status at baseline and subsequent recovery.  The 
suggestion being that patients in employment at baseline are more likely to be in the recovered group at baseline, 
eighteen months and three years later.  These data can be interpreted in two ways, (a) employment brings with it 
a sense of belonging and maintains levels of social support which prevents feelings of isolation which may in 
turn exacerbate the illness, or (b) patients in employment may be able to continue working because they have 
better health scores and these data may simply be reflecting illness severity. 
 
Logistical regression analyses were used to highlight possible mechanisms for predicting positive outcome in 
terms of improvement.  It had already been suggested that a wide range of psychosocial, psychopathological and 
health related factors are associated with prolonging CFS (Surawy, Hackman, Hawton & Sharpe, 1995).  We 
aimed to examine the role of these factors by means of improvement in the condition.  These data suggests that, 
despite the findings reported in previous research, only one measure, namely the current state of health variable 
could accurately predict positive outcome.  When the analyses were re-run using the factors indicated to be 
predictors of outcome in previous research, again only the current state of health variable is indicated as a 
predictor of outcome.  These data should be regarded with caution due to the large confidence intervals involved; 
however, the heterogeneity of CFS may explain the large differences observed.  Although these data are 
interesting, the health status of the patient at initial assessment only exerts (at most) an 18% effect over 
improvement.  There are, therefore, other factors, which we have not yet considered, exerting a greater effect on 
recovery. 
 
5. Conclusion 
 
Overall, the current longitudinal study has provided data indicating that prognosis for the untreated CFS patient 
is poor.  Associations between the state of health measure and other physical and mental health variables have 
been verified using a large group of patients.  The validation of a simple 5-item measure by other standardised 
measures leads us to believe that this score can be used to accurately rate patient illness severity.  We have also 
shown that this measure can predict and assess recovery.  Positive outcome measures are indicated in cases 
where illness length is short and when the number and severity of symptoms are low.  We have confirmed the 
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widely held belief among healthcare professionals that offering care to this patient group before the illness is 
allowed to become entrenched is of major importance if therapy is to be successful.  The measures described 
here can now be used to evaluate the efficacy of treatments in future studies.  Further research is necessary, 
however, to identify the, as yet, unidentified factors which can accurately predict positive outcome in this illness.  
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